Lobbying disclosures · Lobbying report
OGN: second_quarter 2026 lobbying report
Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (Public Law 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing. FY27 appropriations.
Follow OGN- Became public
- Jul 20, 2026, 10:28 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 7:03 AM EST
Why this is connected
Exact legal-name match: Organon & Co. (https://www.sec.gov/Archives/edgar/data/1821825/).
Reported lobbying amounts
Expenses: $320,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/945c8b25-4519-4529-a460-27c1df9e3319/","filing_uuid":"945c8b25-4519-4529-a460-27c1df9e3319","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/945c8b25-4519-4529-a460-27c1df9e3319/print/","filing_document_content_type":"text/html","income":null,"expenses":"320000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Nick Schemmel","dt_posted":"2026-07-20T10:28:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"30 Hudson St.","registrant_address_2":"33rd Floor","registrant_different_address":false,"registrant_city":"Jersey City","registrant_state":"NJ","registrant_zip":"07302","registrant":{"id":401106108,"url":"https://lda.gov/api/v1/registrants/401106108/","house_registrant_id":null,"name":"ORGANON & CO.","description":"Global Healthcare","address_1":"30 Hudson St.","address_2":"33rd Floor","address_3":null,"address_4":null,"city":"Jersey City","state":"NJ","state_display":"New Jersey","zip":"07302","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICK SCHEMMEL","contact_telephone":"+1 201-885-8089","dt_updated":"2026-07-30T09:48:36.083247-04:00"},"client":{"id":210574,"url":"https://lda.gov/api/v1/clients/210574/","client_id":12,"name":"ORGANON & CO.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-05-03"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (Public Law 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":112844,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"SCHEMMEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147774,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"SHACKELFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152518,"prefix":null,"prefix_display":null,"first_name":"KEVIN","nickname":null,"middle_name":null,"last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY27 appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147774,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"SHACKELFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152518,"prefix":null,"prefix_display":null,"first_name":"KEVIN","nickname":null,"middle_name":null,"last_name":"RODGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112844,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"SCHEMMEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in OGN
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Aug 10, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Aug 5, 2026 · disclosed Aug 10, 2026 · Joint
- Nov 24, 2025$1K–$15K
Sen. Gary C. Peters (D-MI)
$1K–$15K · Traded Jul 10, 2025 · disclosed Nov 24, 2025 · filed 137 days later
- Nov 8, 2023$1K–$15K
- Jul 9, 2021$1K–$15K
Sen. John W. Hickenlooper (D-CO)
$1K–$15K · Traded Jun 28, 2021 · disclosed Jul 9, 2021
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.